Key corporate presentation. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS) ...
Celcuity Inc. (Nasdaq: CELC) is a clinical-stage biotechnology company focused on the development of targeted therapies for a number of different cancers.
The Investor Relations website contains information about Scholastic Corporation's business for stockholders, potential investors, and financial analysts.
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer.
The Investor Relations website contains information about Carrols Restaurant Group, Inc.'s business for stockholders, potential investors, and financial ...
8 days ago · Cellectis (CLLS) Investor Presentation - Slideshow · SA TranscriptsSun, Jun. 19, 2022. Cellectis S.A.'s (CLLS) CEO Andre Choulika on Q1 2022 ...
Missing: relations | Show results with:relations
Investor Relations · Corporate Overview · Latest News · Latest Events · Latest Quarterly Reports · Contact Us · Quick Links · Investor Email Alerts · Email Alert Sign ...